Kirstin L Krall

Title: Kirstin L Krall: Innovator in Antibody Compositions

Introduction

Kirstin L Krall is a notable inventor based in San Jose, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibody compositions. Her work focuses on innovative methods that can potentially impact cancer treatment.

Latest Patents

Kirstin L Krall holds 1 patent for her invention titled "PCan065 antibody compositions and methods of use." This invention provides isolated anti-PCan065 antibodies that specifically bind to PCan065. The patent also encompasses compositions that include an anti-PCan065 antibody and a carrier, which can be utilized in various applications, including articles of manufacture or kits. Additionally, the invention details an isolated nucleic acid encoding an anti-PCan065 antibody, as well as an expression vector that comprises this isolated nucleic acid. Furthermore, it includes methods for producing the anti-PCan065 antibodies and for treating PCan065-expressing cancer cells.

Career Highlights

Kirstin L Krall is currently associated with Diadexus, Inc., where she continues to advance her research and development efforts. Her work is pivotal in the ongoing exploration of therapeutic options for cancer treatment.

Collaborations

Kirstin collaborates with Rong A Fan, who is also a key contributor in her field. Their partnership enhances the research capabilities and innovation potential within their projects.

Conclusion

Kirstin L Krall's contributions to antibody compositions represent a significant advancement in biotechnology and cancer treatment. Her innovative work continues to pave the way for future developments in the field.